Adia Med Inc (ADIA)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003	FY 2002
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
Adia Med	245.96K	-	-	-	-
Adia Labs	448.89K	-	-	-	-
Biolete	3.39K	6.38K	-	-	-
Unallocated Corporate	2.27K	-	-	-	-
Total	700.51K	6.38K	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003	FY 2002
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
United States	700.51K	6.38K	-	-	-
Total	700.51K	6.38K	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error